Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients

Published:2022-02-14 Issue:3 Volume:89 Page:393-400
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ramalingam Ravi^ORCID,Kaur Harpreet^ORCID,Scott Julius Xavier,Sneha Latha M.,Arunkumar Ganeshprasad,Srinivasan Arathi,Paul Solomon F. D.^ORCID

Funder

Council of Scientific and Industrial Research, India

Department of Biotechnology, Government of West Bengal

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-022-04405-7.pdf

Reference46 articles.

1. Longo DL, Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373(16):1541–1552. https://doi.org/10.1056/nejmra1400972

2. Moon W, Loftus EV (2016) Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther 43(8):863–883. https://doi.org/10.1111/apt.13559

3. Rudin S, Marable M, Huang RS (2017) The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment. Genomics Proteomics Bioinformatics 15(2):82–93. https://doi.org/10.1016/j.gpb.2016.11.003

4. Fukino K, Kawashima T, Suzuki M et al (2007) Methylenetetrahydrofolate reductase and reduced folate carrier-1 genotypes and methotrexate serum concentrations in patients with rheumatoid arthritis. J Toxicol Sci 32(4):449–452. https://doi.org/10.2131/jts.32.449

5. Laverdie C, Chiasson S, Costea I et al (2002) Brief report Polymorphism G 80 A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100(10):3832–3834. https://doi.org/10.1182/blood.v100.10.3832

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning in paediatric haematological malignancies: a systematic review of prognosis, toxicity and treatment response models;Pediatric Research;2024-08-31

2. GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS;Experimental Oncology;2024-02-03

3. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia;European Journal of Pediatrics;2023-10-18

4. Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures;Frontiers in Endocrinology;2023-09-26

5. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia;2023-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3